Schwannoma medical therapy: Difference between revisions
Jump to navigation
Jump to search
| (2 intermediate revisions by the same user not shown) | |||
| Line 8: | Line 8: | ||
* There is no obvious medical treatment for schwannomas other than managing the symptoms. | * There is no obvious medical treatment for schwannomas other than managing the symptoms. | ||
===Radiotherapy=== | ===Radiotherapy=== | ||
Stereotactic | |||
* Stereotactic radiosurgery (SRS) <ref name="pmid28546250">{{cite journal |vauthors=Lin EP, Crane BT |title=The Management and Imaging of Vestibular Schwannomas |journal=AJNR Am J Neuroradiol |volume=38 |issue=11 |pages=2034–2043 |date=November 2017 |pmid=28546250 |pmc=5690865 |doi=10.3174/ajnr.A5213 |url=}}</ref><ref name="pmid28409393">{{cite journal |vauthors=Persson O, Bartek J, Shalom NB, Wangerid T, Jakola AS, Förander P |title=Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review |journal=Acta Neurochir (Wien) |volume=159 |issue=6 |pages=1013–1021 |date=June 2017 |pmid=28409393 |pmc=5425507 |doi=10.1007/s00701-017-3164-6 |url=}}</ref><ref name="pmid22931906">{{cite journal |vauthors=Mulder JJ, Kaanders JH, van Overbeeke JJ, Cremers CW |title=Radiation therapy for vestibular schwannomas |journal=Curr Opin Otolaryngol Head Neck Surg |volume=20 |issue=5 |pages=367–71 |date=October 2012 |pmid=22931906 |doi=10.1097/MOO.0b013e328357d337 |url=}}</ref> | |||
* Fractionated stereotactic radiotherapy (FSRT) | |||
SRS is the most commonly used between these as it causes minimal injury to adjacent tissues. However, there is a risk of progressive hearing deterioration associated with radiotherapy for vestibular schwannomas. | |||
==References== | ==References== | ||
Latest revision as of 01:31, 28 October 2019
|
Schwannoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Schwannoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Schwannoma medical therapy |
|
Risk calculators and risk factors for Schwannoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
Medical therapy
- There is no obvious medical treatment for schwannomas other than managing the symptoms.
Radiotherapy
SRS is the most commonly used between these as it causes minimal injury to adjacent tissues. However, there is a risk of progressive hearing deterioration associated with radiotherapy for vestibular schwannomas.
References
- ↑ Lin EP, Crane BT (November 2017). "The Management and Imaging of Vestibular Schwannomas". AJNR Am J Neuroradiol. 38 (11): 2034–2043. doi:10.3174/ajnr.A5213. PMC 5690865. PMID 28546250.
- ↑ Persson O, Bartek J, Shalom NB, Wangerid T, Jakola AS, Förander P (June 2017). "Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review". Acta Neurochir (Wien). 159 (6): 1013–1021. doi:10.1007/s00701-017-3164-6. PMC 5425507. PMID 28409393.
- ↑ Mulder JJ, Kaanders JH, van Overbeeke JJ, Cremers CW (October 2012). "Radiation therapy for vestibular schwannomas". Curr Opin Otolaryngol Head Neck Surg. 20 (5): 367–71. doi:10.1097/MOO.0b013e328357d337. PMID 22931906.